Update in the pharmaceutical therapy of the irritable bowel syndrome-Reference-Cited by-同舟云学术

Update in the pharmaceutical therapy of the irritable bowel syndrome

Published:2004-04-29 Issue:4 Volume:58 Page:374-381
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:

Author:

Thielecke F.,Maxion-Bergemann S.,Abel F.,Gonschior A-K.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1368-5031.2004.00136.x/fullpdf

Reference63 articles.

1. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome;Saito;Dig Dis Sci,2000

2. Epidemiological characteristics and socioeconomic importance of irritable bowel syndrome;Balboa;Rev Esp Enferm Dig,2000

3. Irritable bowel syndrome in the general population;Jones;BMJ,1992

4. Irritable bowel syndrome: a multibillion-dollar problem;Longstreth;Gastroenterology,1995

5. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact;Drossman;Dig Dis Sci,1993

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome;Peptides;2022-01

2. Neurochemical bases of visceral nociception: Mathematical model;Journal of Theoretical Biology;2007-11

3. MECHANISMS MEDIATING SEROTONIN-INDUCED CONTRACTION OF COLONIC MYOCYTES;Clinical and Experimental Pharmacology and Physiology;2007-01

4. CRF1 Receptors as a Therapeutic Target for Irritable Bowel Syndrome;Current Pharmaceutical Design;2006-11-01

5. Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers;Alimentary Pharmacology and Therapeutics;2006-03